IL7 and cancer: Administration of IL-7 can potentially enhance the function of immune cells and allow a larger lymphocyte pool to develop in vivo, and when used as an adjuvant in immunizations, IL-7 has been shown to improve long-term, antigen-specific T cell responses [15], However, dysregulation of the IL-7 pathway can contribute to the development of cancer [16].